Telegraph Hill Partners is a venture capital firm based in San Francisco, CA, specializing in providing growth capital and strategic guidance to life science, medical device, and healthcare companies. With a focus on partnering with innovative organizations, they invest in high-quality companies with novel technologies and strong management teams, helping them become world-class businesses.
Through their experienced team, Telegraph Hill Partners efficiently drives growth and profitability while maintaining the vision and integrity of the organizations they work with, aiming to help these companies achieve their growth objectives. Their portfolio includes companies such as Seer and Panome Bio, which have made significant advancements in the fields of multi-omics services and next-generation metabolomics proteomics.
Generated from the website